People: ANI Pharmaceuticals Inc (ANIP.OQ)

ANIP.OQ on NASDAQ Stock Exchange Global Market

1:30am IST
Change (% chg)

$0.98 (+3.28%)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low

Haughey, Thomas 

Mr. Thomas J. Haughey J.D. serves as Independent Director of the Company. He held the role of General Counsel and Secretary at Par Pharmaceutical Companies, Inc. (“Par”) from 2003 through 2016. In addition to his role as General Counsel, he has held various additional executive roles at Par including President from 2011 to 2012 and, most recently, Chief Administrative Officer from 2012 to 2016. Prior to that, Mr. Haughey held positions at Schering-Plough Corporation, where he was Chief Counsel from 1998 to 2001 and Legal Director from 2001 to 2003. Previously, Mr. Haughey was an attorney at Cadwalader Wickersham & Taft and a certified public accountant at Arthur Anderson & Co. Mr. Haughey earned a B.S. in accounting at St. John’s University and a J.D. at the New York University School of Law. Mr. Haughey is the current Chair of the Board’s Audit and Finance Committee and is a member of the Board’s Compensation Committee. Mr. Haughey qualifies as an audit committee financial expert. If re-elected, Mr. Haughey will continue to serve as the Chair of the Board’s Audit and Finance Committee, and will serve as a member of the Board’s Compensation Committee and Nominating and Corporate Governance Committee. Mr. Haughey is nominated for re-election based on his experience in the pharmaceutical industry as well as his legal, financial and accounting expertise.

Basic Compensation

Total Annual Compensation, USD 89,025
Restricted Stock Award, USD 132,182
Long-Term Incentive Plans, USD --
All Other, USD 94,071
Fiscal Year Total, USD 315,278

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

Robert Brown


Patrick Walsh


Stephen Carey


Robert Schrepfer


James Marken


Thomas Haughey

As Of  31 Dec 2019